The cash position is clearly holding down the share price. Do you see any non-dilutive financing possible before the end of this calendar year?
Bladerunner
That's not something I'd have any insight into; I do know that the CAR-T folks at pharma companies are watching this technology closely so maybe that will lead to an earlier partnership than later? But they watch a lot of things and I don't even know if MRKR is looking to partner yet.
But as I said before I believe their cash position is fine through the end of next year so it is hardly an urgent need.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.